Task: Answer the MCQ question.
Query: Which drug exhibits a -48.798% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a. CCOc1ccc(-n2c(-c3cccs3)nc3ccccc3c2=O)cc1
b. CCCn1ncc(CN2CCCC(C(=O)c3cccc(OC(C)C)c3)C2)c1C
Answer: b. CCCn1ncc(CN2CCCC(C(=O)c3cccc(OC(C)C)c3)C2)c1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCn1ncc(CN2CCCC(C(=O)c3cccc(OC(C)C)c3)C2)c1C
CCCn1ncc(CN2CCCC(C(=O)c3cccc(OC(C)C)c3)C2)c1C
[1-[(5-methyl-1-propylpyrazol-4-yl)methyl]piperidin-3-yl]-(3-propan-2-yloxyphenyl)methanone